Oral LDL Cholesterol Medicines

Which oral medicines can lower LDL cholesterol?

Statins lower LDL cholesterol by reducing cholesterol production in the liver and increasing removal of circulating LDL particles. They have extensive evidence showing fewer heart attacks, ischemic strokes and cardiovascular deaths, so clinical guidelines generally recommend them first for patients whose cardiovascular risk warrants medication.

Ezetimibe limits intestinal cholesterol absorption and can be added when a statin alone does not achieve an appropriate LDL level. Bempedoic acid inhibits ATP citrate lyase, an enzyme upstream of the statin target in the liver. It may be considered for selected patients who require further LDL reduction or cannot tolerate recommended statin therapy.

Does lowering LDL with a pill prevent heart attacks?

The CLEAR Outcomes trial enrolled 13,970 statin-intolerant patients with, or at high risk for, cardiovascular disease. Published in the New England Journal of Medicine in 2023, it found that bempedoic acid lowered LDL cholesterol by approximately 21% relative to placebo after six months and reduced the trial's primary composite cardiovascular outcome by 13% over a median follow-up of about 41 months.

These findings reinforce an important distinction: an impressive laboratory result is not automatically proof that a drug prevents disability or death. Clinicians also examine randomized evidence for heart attacks, strokes, revascularization procedures, adverse effects and long-term adherence before deciding where a new LDL-lowering medicine belongs in treatment.

How should patients choose an LDL-lowering treatment?

A clinician may begin by confirming how a patient took previous statins, reviewing interacting medicines and considering a lower dose or different statin when muscle symptoms occur. Many people with prior symptoms can tolerate another regimen, while patients with persistent intolerance may need a non-statin medicine.

Bempedoic acid can increase uric acid and may contribute to gout; its prescribing information also includes other clinically important precautions. Patients should not stop a statin or replace prescribed treatment because of a headline. A shared decision should consider absolute cardiovascular risk, expected benefit, safety, cost and the amount of additional LDL reduction required.